BERLIN/FRANKFURT, Oct 29 (Reuters) - The following are some of the factors that may move German stocks on Tuesday:
9M sales due.
German exchange operator Deutsche Boerse on Monday posted a 10% rise in third-quarter net profit thanks to increased trading in derivatives markets as well as power and gas markets and the company confirmed its targets for the full year.
The company said it confirmed its outlook as the group grew by 5% organically in the third quarter.
The dialysis company confirmed its outlook after the third quarter.
EU authorities have approved Merck’s Avelumab drug for a treatment of advanced renal cancer.
Volkswagen is ramping up production of electric cars to around 1 million vehicles by end of 2022, according to manufacturing plans seen by Reuters, enabling the German carmaker to leapfrog Tesla Inc and making China the key battleground.
The German lender posted a preliminary 35% rise in third-quarter net profit on Monday as reduced costs and higher revenue helped it exceed expectations, although performance at its corporate client unit remained weak.
9M results due.
Q3 results due.
Israeli automotive technology startup Tactile Mobility said on Tuesday it secured $9 million in funding from Porsche, Union Tech Ventures and previous investors.
The German drugmaker on Monday said it stopped the clinical development program of MOR106 in Atopic dermatitis for efficacy reasons.
GEA GROUP AG: CFRA raises to “sell” from “strong sell”
Dow Jones +0.5%, S&P 500 +0.6%, Nasdaq +1.0% at close.
Nikkei +0.5%, Shanghai stocks -0.6%.
Time: 6:08 GMT
No major economic data scheduled.
REUTERS TOP NEWS ($1 = 0.9017 euros) (Reporting by Berlin Speed Desk and Frankfurt Newsroom)